Literature DB >> 7399394

Heterogeneity of plasma motilin in patients with chronic renal failure.

K Shima, S Shin, A Tanaka, E Hashimura, T Nishino, K Imagawa, Y Kumahara, N Yanaihara.   

Abstract

Plasma immunoreactive motilin (IRM) concentrations were strikingly higher in patients with chronic renal failure (CRF) than in normal subjects. IRM in azotemic plasma was heterogeneous in gel-filtration profile. The first peak eluted in the void volume of the column and the second and the third one, comprising a major portion of IRM content, came out coincidentally with insulin and authentic motilin, respectively. By contrast, no discernible amount of IRM was found in the region corresponding with the second peak in gel-filtration of the plasma from normals and very little in a patient with ileus whole plasma IRM level was elevated. The hypermotilinemia and the accumulation of this high molecular weight motilin in patients with CRF suggest that the kidney plays some role in the elimination of motilin, and further, that the clearance of the high molecular motilin is more dependent on renal function than that of authentic motilin. The present paper emphasizes the necessity for clarifying the significance of the heterogeneity of IRM in CRF.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7399394     DOI: 10.1055/s-2007-996281

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  5 in total

1.  Disturbed initiation of gastric interdigestive migrating complexes despite high plasma motilin levels in patients with low gastric pH.

Authors:  M Kusano; T Sekiguchi; O Kawamura; K Kikuchi; K Nakamura; M Mori
Journal:  Dig Dis Sci       Date:  1998-08       Impact factor: 3.199

2.  Effect of erythromycin derivative EM523L on human interdigestive gastrointestinal tract.

Authors:  O Kawamura; T Sekiguchi; Z Itoh; S Omura
Journal:  Dig Dis Sci       Date:  1993-06       Impact factor: 3.199

3.  Gastric acid inhibits antral phase III activity in duodenal ulcer patients.

Authors:  M Kusano; T Sekiguchi; T Nishioka; O Kawamura; K Kikuchi; T Matsuzaki; T Horikoshi
Journal:  Dig Dis Sci       Date:  1993-05       Impact factor: 3.199

4.  Pharmacokinetic and pharmacodynamic studies of SK-896, a new human motilin analogue, in healthy male volunteers.

Authors:  Yoshiyuki Furuta; Yukiharu Nakayama; Mitsuyoshi Nakashima; Yoshio Suzuki
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

5.  Distal Colon Motor Dysfunction in Mice with Chronic Kidney Disease: Putative Role of Uremic Toxins.

Authors:  Elsa Hoibian; Nans Florens; Laetitia Koppe; Hubert Vidal; Christophe O Soulage
Journal:  Toxins (Basel)       Date:  2018-05-16       Impact factor: 4.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.